Bluejay Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BJDX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
13 Dec 23	BuyUS$1,535	Svetlana Dey	Individual		500	US$3.07
13 Dec 23	BuyUS$1,635	Indranil Dey	Individual		500	US$3.27

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 162.8%.

Top 16 shareholders own 30.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.61%	Lana Management & Business Research International, LLC	204,567	US$108.4k	0%	no data
7.24%	Armistice Capital LLC	194,525	US$103.1k	703%	no data
6.13%	Douglas Wurth	164,761	US$87.3k	-2.96%	no data
5.58%	Sabby Management, LLC	149,926	US$79.5k	607%	0.48%
1.42%	Donald Chase	38,267	US$20.3k	-0.39%	no data
1.06%	Indranil Dey	28,526	US$15.1k	0%	no data
0.82%	Citadel Advisors LLC	22,077	US$11.7k	0%	no data
0.21%	Kenneth Fisher	5,659	US$3.0k	0%	no data
0.12%	Geode Capital Management, LLC	3,279	US$1.7k	0.46%	no data
0.12%	Tower Research Capital LLC	3,252	US$1.7k	126%	no data
0.084%	Jason Cook	2,245	US$1.2k	-52.6%	no data
0.056%	Svetlana Dey	1,500	US$794.9	0%	no data
0.03%	The Vanguard Group, Inc.	794	US$420.8	0%	no data
0.0023%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	61	US$32.3	-71.1%	no data
0.00093%	Osaic Wealth, Inc. , Asset Management Arm	25	US$13.3	0%	no data
0.00022%	Wells Fargo & Company, Private Banking and Investment Banking Arm	6	US$3.1	50%	no data